glucose, (beta-d)-isomer has been researched along with Parkinson Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 10 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, JC; He, ZQ; Huan, PF; Wang, L | 1 |
| André-Miral, C; Arbo, BD; Dos Santos, MG; Hort, MA; Muccillo-Baisch, AL; Schimith, LE | 1 |
| Abdelraouf, SM; Al-Kady, RH; Motawi, TK; Senousy, MA | 1 |
| Li, L; Yao, W | 1 |
| Dong, HY; Jin, M; Li, HY; Li, LB; Liu, DS; Luo, N; Rong, H; Wang, JP; Zhang, JY; Zhang, XJ; Zhang, YB | 1 |
| Gu, RZ; Lan, R; Lang, XY; Li, XX; Liu, QS; Qin, XY; Yu, Y | 1 |
| Fu, B; Li, R; Yan, T; Zhang, X; Zhang, Y; Zhu, L | 1 |
| Yang, H; Zhang, L | 1 |
| Arab, HH; Safar, MM; Shahin, NN | 1 |
| Aibaidula, Y; Aimaiti, M; Aisa, Y; Chen, Q; Feng, X; Lei, X; Mi, N; Wumaier, A; Xirepu, X; Zhang, Y | 1 |
| He, J; Li, X; Li, Y; Lin, X; Liu, Y; Xiu, M; Yang, S | 1 |
| Chen, G; Fu, S; Guo, W; He, D; Huang, B; Kan, X; Li, Y; Liu, D; Liu, J; Meng, T; Ran, X; Wang, W | 1 |
| Cai, F; Chen, S; Gu, C; Mao, G; Wang, G; Wang, J; Yan, J; Yang, Z | 1 |
| Cao, X; Li, Z; Yan, J; Yang, Z; Zhao, N | 1 |
| Fu, Q; Liu, X; Wang, Y; Wu, Z | 1 |
| Chen, J; Chen, L; Hao, D; Huang, L; Zhang, L | 1 |
| Ferdous, S; Ghori, NU; Mirza, AH; Mirza, MU | 1 |
| Cai, H; Chen, Y; Gong, S; Liao, FF; Liao, Z; Wang, B; Wang, C; Wang, GH; Xu, JP; Zhang, DQ; Zhang, MZ | 1 |
| Gu, XS; Hu, LF; Liu, CF; Liu, S; Mao, CJ; Wang, F; Yang, J; Yang, YP; Zhang, CY | 1 |
| He, X; Ren, J; Wang, Y; Yuan, J; Zhao, Y | 1 |
| Cao, YB; Hu, LF; Li, J; Liu, CF; Sun, X; Wang, F; Yang, YP | 1 |
| Gadad, BS; Pullabhatla, S; Rao, KS; Shantharam, IS; Subramanya, PK | 1 |
| Lei, L; Li, C; Pu, X; Sheng, G; Tu, P | 1 |
| Li, Q; Li, YY; Lu, JH; Pu, XP; Zhao, YY | 1 |
| Smith, PF | 1 |
3 review(s) available for glucose, (beta-d)-isomer and Parkinson Disease
| Article | Year |
|---|---|
Polydatin as a therapeutic alternative for central nervous system disorders: A systematic review of animal studies.
Topics: Animals; Glucosides; Male; Neuroprotective Agents; Parkinson Disease; Stilbenes | 2022 |
The Therapeutic Potential of Salidroside for Parkinson's Disease.
Topics: Animals; Glucosides; Parkinson Disease; Phosphatidylinositol 3-Kinases; Signal Transduction | 2023 |
Inflammation in Parkinson's disease: an update.
Topics: Animals; Anti-Inflammatory Agents; Benzoates; Bridged-Ring Compounds; Diterpenes; Drug Evaluation, Preclinical; Glucosides; Humans; Inflammation; Monoterpenes; Parkinson Disease; Phenanthrenes; Purines | 2008 |
22 other study(ies) available for glucose, (beta-d)-isomer and Parkinson Disease
| Article | Year |
|---|---|
Paeoniflorin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
Topics: Animals; Cognitive Dysfunction; Dopaminergic Neurons; Glucosides; Mice; Molecular Docking Simulation; Monoterpenes; Parkinson Disease; Signal Transduction; Tumor Suppressor Protein p53 | 2022 |
Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78/PERK/eIF2α/CHOP pathway and miR-211-5p.
Topics: alpha-Synuclein; Animals; Apoptosis; Autophagy; Beclin-1; Benzhydryl Compounds; Catalase; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Glucosides; Heat-Shock Proteins; MicroRNAs; Parkinson Disease; Rats; Rotenone; Transcription Factor CHOP | 2022 |
Total Glucosides of White Paeony Capsule ameliorates Parkinson's disease-like behavior in MPTP-induced mice model by regulating LRRK2/alpha-synuclein signaling.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Disease Models, Animal; Dopaminergic Neurons; Glucosides; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Neuroprotective Agents; Paeonia; Parkinson Disease | 2024 |
2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates MPP+/MPTP-induced neurotoxicity in vitro and in vivo by restoring the BDNF-TrkB and FGF2-Akt signaling axis and inhibition of apoptosis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Survival; Dopaminergic Neurons; Drugs, Chinese Herbal; Fallopia multiflora; Fibroblast Growth Factor 2; Glucosides; Humans; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stilbenes | 2019 |
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
Topics: Animals; Disease Models, Animal; Glucosides; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Phenols; Pyroptosis; Signal Transduction | 2020 |
Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons.
Topics: Animals; Cell Differentiation; Cells, Cultured; Dopaminergic Neurons; Female; Glucosides; Mesencephalon; Mice; Mice, Inbred BALB C; Neural Stem Cells; Parkinson Disease; Pregnancy; Stilbenes; Wnt Signaling Pathway | 2021 |
Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model.
Topics: Animals; Benzhydryl Compounds; Glucosides; Glycogen Synthase Kinase 3 beta; Mice; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Rotenone | 2021 |
Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study.
Topics: Adenylate Kinase; alpha-Synuclein; Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Computational Biology; Drosophila melanogaster; Glucosides; HEK293 Cells; Humans; Longevity; Membrane Potential, Mitochondrial; Models, Biological; Motor Activity; Neurons; Neuroprotective Agents; Parkinson Disease; Phenols; Rats; Reactive Oxygen Species; Rotenone | 2021 |
Gastrodin extends the lifespan and protects against neurodegeneration in the Drosophila PINK1 model of Parkinson's disease.
Topics: Animals; Benzyl Alcohols; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Drugs, Chinese Herbal; Female; Gastrodia; Glucosides; Humans; Longevity; Male; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Protein Serine-Threonine Kinases | 2021 |
Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
Topics: Animals; Cell Line; Cytokines; Dopaminergic Neurons; Glucosides; Glycogen Synthase Kinase 3 beta; Lipopolysaccharides; Mice; Microglia; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Stilbenes; Substantia Nigra | 2018 |
Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling.
Topics: alpha-Synuclein; Autophagy; Cell Line; Glucosides; Humans; Neuroprotective Agents; Parkinson Disease; Phenols; Point Mutation; Rhodiola; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Benzyl Alcohols; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Chemotaxis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Glucosides; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptor, Insulin; Signal Transduction | 2019 |
Gastrodin ameliorates Parkinson's disease by downregulating connexin 43.
Topics: Animals; Astrocytes; Benzyl Alcohols; Cell Communication; Connexin 43; Disease Models, Animal; Down-Regulation; Gap Junctions; Gene Expression Regulation; Glucosides; Parkinson Disease; Phosphorylation; Rats; Rotenone | 2013 |
Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis Regulatory Proteins; Ataxia; Behavior, Animal; Cell Survival; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Glucosides; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Parkinson Disease; Proto-Oncogene Proteins c-akt; Signal Transduction; Stilbenes; Substantia Nigra; Tyrosine 3-Monooxygenase | 2013 |
Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.
Topics: Binding Sites; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucosides; Glycyrrhetinic Acid; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Parkinson Disease; Phytotherapy; Plants; Receptors, Dopamine D3; Stilbenes; Structure-Activity Relationship | 2015 |
Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopaminergic Neurons; Glucosides; Male; Mice, Inbred C57BL; Motor Neurons; Nerve Degeneration; Neuroprotective Agents; Oxidants; Oxidative Stress; Parkinson Disease; Rats, Sprague-Dawley; Stilbenes; Substantia Nigra | 2015 |
Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
Topics: Acid Sensing Ion Channels; Animals; Autophagy; Bridged-Ring Compounds; Dopamine; Dopaminergic Neurons; Glucosides; Male; Monoterpenes; Neuroprotective Agents; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Sprague-Dawley | 2016 |
Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Caspase 3; Disease Models, Animal; Glucosides; Humans; Microtubule-Associated Proteins; Molecular Dynamics Simulation; Parkinson Disease; Phenols; Protein Binding; Rats; Rats, Sprague-Dawley; Rotenone | 2016 |
ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation.
Topics: 1-Methyl-4-phenylpyridinium; Acid Sensing Ion Channels; Acidosis; alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Benzoates; Bridged-Ring Compounds; Cytoprotection; Glucosides; Microtubule-Associated Proteins; Monoterpenes; Nerve Tissue Proteins; Neurons; Parkinson Disease; PC12 Cells; Rats; Sodium Channels; Vacuoles | 2011 |
Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
Topics: alpha-Synuclein; Calorimetry; Curcumin; Dose-Response Relationship, Drug; Drug Design; Glucosides; Parkinson Disease; Protein Binding; Protein Multimerization; Solubility | 2012 |
Tubuloside B from Cistanche salsa rescues the PC12 neuronal cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis and oxidative stress.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Apoptosis; Cistanche; DNA Fragmentation; Electrophoresis, Agar Gel; Flow Cytometry; Glucosides; Microscopy, Confocal; Oxidative Stress; Parkinson Disease; PC12 Cells; Phytotherapy; Rats; Reactive Oxygen Species | 2002 |
Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP+) in primary cultures of rat mesencephalic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Buddleja; Caspase 3; Cell Death; Cell Survival; Gene Expression Regulation, Enzymologic; Glucosides; Iridoid Glucosides; Iridoids; Medicine, Chinese Traditional; Mesencephalon; Neurons; Neuroprotective Agents; Parkinson Disease; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2008 |